Brooktree Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.94M | Buy |
121,355
+3,184
| +3% | +$77.2K | 1.92% | 12 |
|
|
2025
Q1 | $2.99M | Buy |
118,171
+2,788
| +2% | +$70.6K | 2.25% | 11 |
|
|
2024
Q4 | $3.06M | Buy |
115,383
+1,389
| +1% | +$36.9K | 2.27% | 12 |
|
|
2024
Q3 | $3.3M | Buy |
113,994
+1,316
| +1% | +$38.1K | 2.68% | 12 |
|
|
2024
Q2 | $3.15M | Sell |
112,678
-8,574
| -7% | -$240K | 2.7% | 12 |
|
|
2024
Q1 | $3.36M | Buy |
121,252
+6,117
| +5% | +$170K | 2.6% | 14 |
|
|
2023
Q4 | $3.31M | Sell |
115,135
-9,877
| -8% | -$284K | 2.68% | 15 |
|
|
2023
Q3 | $4.15M | Buy |
125,012
+3,640
| +3% | +$121K | 3.46% | 13 |
|
|
2023
Q2 | $4.45M | Sell |
121,372
-4,228
| -3% | -$155K | 3.38% | 12 |
|
|
2023
Q1 | $5.12M | Sell |
125,600
-1,659
| -1% | -$67.7K | 3.99% | 12 |
|
|
2022
Q4 | $6.52M | Sell |
127,259
-2,557
| -2% | -$131K | 5.36% | 8 |
|
|
2022
Q3 | $5.68M | Buy |
129,816
+5,650
| +5% | +$247K | 4.68% | 8 |
|
|
2022
Q2 | $6.51M | Buy |
124,166
+2,621
| +2% | +$137K | 4.89% | 9 |
|
|
2022
Q1 | $6.29M | Buy |
121,545
+8,432
| +7% | +$436K | 4.1% | 9 |
|
|
2021
Q4 | $6.68M | Sell |
113,113
-1,206
| -1% | -$71.2K | 4.08% | 9 |
|
|
2021
Q3 | $4.92M | Buy |
114,319
+2,302
| +2% | +$99K | 3.13% | 12 |
|
|
2021
Q2 | $4.39M | Buy |
112,017
+17,348
| +18% | +$679K | 2.82% | 12 |
|
|
2021
Q1 | $3.43M | Buy |
94,669
+1,965
| +2% | +$71.2K | 2.3% | 16 |
|
|
2020
Q4 | $3.41M | Sell |
92,704
-6,109
| -6% | -$225K | 2.51% | 12 |
|
|
2020
Q3 | $3.44M | Buy |
98,813
+4,389
| +5% | +$153K | 2.91% | 11 |
|
|
2020
Q2 | $2.93M | Buy |
94,424
+1,657
| +2% | +$51.4K | 2.75% | 13 |
|
|
2020
Q1 | $2.87M | Buy |
92,767
+16,725
| +22% | +$518K | 3.33% | 11 |
|
|
2019
Q4 | $2.83M | Buy |
+76,042
| New | +$2.83M | 2.59% | 17 |
|